FT
MRNA icon

Fiduciary Trust’s Moderna MRNA Stock Holding History

Fiduciary Trust’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$239K Buy
+3,412
New +$177K ﹤0.01% 823
2025
Q3 		– Sell
-162,974
Closed -$4.5M – 865
2025
Q2 		$4.5M Buy
162,974
+559
+0.3% +$14.7K 0.06% 182
2025
Q1 		$4.6M Buy
162,415
+423
+0.3% +$15K 0.06% 181
2024
Q4 		$6.74M Buy
161,992
+9
+0% +$430 0.09% 136
2024
Q3 		$10.8M Sell
161,983
-1,062
-0.7% -$97.5K 0.15% 100
2024
Q2 		$19.4M Sell
163,045
-56,000
-26% -$7.09M 0.29% 60
2024
Q1 		$23.3M Sell
219,045
-288
-0.1% -$29K 0.36% 54
2023
Q4 		$21.8M Sell
219,333
-15
-0% -$1.26K 0.36% 51
2023
Q3 		$22.7M Buy
219,348
+268
+0.1% +$29.9K 0.41% 46
2023
Q2 		$26.6M Sell
219,080
-17
-0% -$2.27K 0.47% 44
2023
Q1 		$33.6M Hold
219,097
– – 0.62% 32
2022
Q4 		$39.4M Sell
219,097
-52,983
-19% -$8.66M 0.77% 24
2022
Q3 		$32.2M Buy
272,080
+6
+0% +$910 0.7% 27
2022
Q2 		$38.9M Buy
272,074
+145
+0.1% +$20.7K 0.82% 23
2022
Q1 		$46.8M Hold
271,929
– – 0.84% 21
2021
Q4 		$69.1M Sell
271,929
-700
-0.3% -$205K 1.14% 14
2021
Q3 		$105M Buy
272,629
+271,297
+20,368% +$100M 1.87% 8
2021
Q2 		$313K Sell
1,332
-599,988
-100% -$107M 0.01% 547
2021
Q1 		$78.7M Sell
601,320
-499,931
-45% -$72.4M 1.6% 9
2020
Q4 		$115M Sell
1,101,251
-821,723
-43% -$83.1M 2.4% 6
2020
Q3 		$136M Hold
1,922,974
– – 3.21% 6
2020
Q2 		$123M Sell
1,922,974
-299,900
-13% -$16.4M 3.06% 6
2020
Q1 		$66.6M Sell
2,222,874
-1,040,094
-32% -$23.9M 1.93% 8
2019
Q4 		$63.8M Sell
3,262,968
-400,000
-11% -$7.1M 1.49% 10
2019
Q3 		$58.3M Sell
3,662,968
-610,000
-14% -$9.01M 1.46% 11
2019
Q2 		$62.6M Sell
4,272,968
-38,958
-0.9% -$837K 1.64% 10
2019
Q1 		$87.7M Sell
4,311,926
-1
-0% -$19 2.36% 8
2018
Q4 		$65.8M Buy
+4,311,927
New +$70.9M 2.02% 9

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Fiduciary Trust's MRNA Position: Q2 2026 in Review

Fiduciary Trust opened a new position in Moderna (MRNA) in Q2 2026: 3,412 shares worth $239K. The stake represents ﹤0.01% of the portfolio and ranks #823 among its holdings. This is a return to the name: Fiduciary Trust previously reported a position in MRNA as recently as Q2 2025.

Fiduciary Trust first reported a position in MRNA in Q4 2018 and has held it in 28 quarters since. The position peaked at $136M in Q3 2020. 781 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Fiduciary Trust held 3,412 shares of Moderna worth $239K as of Q2 2026.
  • Moderna was a new Fiduciary Trust position in Q2 2026.
  • Moderna made up ﹤0.01% of Fiduciary Trust's portfolio in Q2 2026, its #823 holding.
  • Fiduciary Trust first reported a position in Moderna in Q4 2018 and has held it in 28 quarters since.
  • Fiduciary Trust's Moderna position peaked at $136M in Q3 2020.
  • 781 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.